INDIAGLYCOIndia Glycols

₹1014.75+0.05%

Market Cap

₹6,285.49 Cr

Stock P/E

25.78

ROCE

12.33%

ROE

10.72%

Book Value

₹373.13

Financials

YoY Net Sales

EPS Growth

Operating Margin

No recent news available for this stock.

Holdings

Distribution

Promoter

Foreign Investors

Domestic Investors

Public

POSITIVES

•
Strong year-on-year margin expansion alongside revenue growth across key segments.
•
Robust growth in Bio-Fuel and Potable Spirits driving topline, with meaningful margin improvements in these segments.

NEGATIVES

•
Ennature Biopharma margins are under pressure due to competition and slowing demand in developed markets.
•
Policy changes in UP/Uttarakhand starting April have caused stock movements and slower growth in key markets.

Peer comparison data is not available for this stock.